Participating in Sports After Mitral Valve Repair for Primary Mitral Regurgitation: A Retrospective Cohort Study.


Journal

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
ISSN: 1536-3724
Titre abrégé: Clin J Sport Med
Pays: United States
ID NLM: 9103300

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 03 07 2018
accepted: 22 02 2019
pubmed: 7 12 2019
medline: 21 10 2021
entrez: 7 12 2019
Statut: ppublish

Résumé

Participating in either competitive or leisure sports is restrictive after surgical mitral valve repair (MVR). In this study, we examine the impact of sports on outcomes after MVR. Retrospective cohort study. Patients aged 18 to 65 years who underwent a first-time MVR for primary mitral regurgitation (MR) in a tertiary care center. One hundred twenty-one consecutive patients were included in the study. The exclusion criteria were as follows: other concomitant procedures, early perioperative death or repeat intervention, noncardiac death or endocarditis during follow-up, and general contraindications for normal physical activity. Participation in sports was quantified by the number of hours per week during the past 6 months, classified according to the Mitchell classification and assessed with the International Physical Activity Questionnaire (IPAQ) short form. The primary composite endpoint was MVR failure defined as MR grade ≥2 or mean transmitral gradient ≥8 mm Hg, signs and symptoms of heart failure, or late-onset postoperative AF (>3 months). The mean age was 50 ± 11 years, and there were 85 (71%) men. The median follow-up was 34 months [interquartile range (IQR): 20-50]. Fifty-six (46%) patients participated in sports regularly (median of 3 h/wk; IQR: 2-5). Twenty (17%) patients reached the primary composite endpoint with no correlation with participation in sports (P = 0.537), IPAQ categories (P = 0.849), in any of the Mitchell classification subgroups and a high level of participation in sports ≥6 hours (P = 0.679). Sports seem to be unrelated to the worst outcome after MVR.

Identifiants

pubmed: 31809282
pii: 00042752-202109000-00003
doi: 10.1097/JSM.0000000000000769
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

414-422

Informations de copyright

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–1243.
Braunberger E, Deloche A, Berrebi A, et al. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation. 2001;104:I8–I11.
Costa FDAD, Colatusso DFF, Martin GLDS, et al. Long-term results of mitral valve repair. Braz J Cardiovasc Surg. 2018;33:23–31.
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Rev Espanola Cardiol Engl Ed. 2018;71:110.
Meurin P, Iliou MC, Ben Driss A, et al. Early exercise training after mitral valve repair: a multicentric prospective French study. Chest. 2005;128:1638–1644.
Maron BJ, Zipes DP, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e256-261.
Mitchell JH, Haskell W, Snell P, et al. Task force 8: classification of sports. J Am Coll Cardiol. 2005;45:1364–1367.
Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816–822; discussion 822–823.
Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17:1086–1119.
Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14:611–644.
Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713; quiz 786–788.
Harjola V-P, Mebazaa A, Čelutkienė J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016;18:226–241.
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791.
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014;148:e1-132.
Committee W, O'Gara PT, Grayburn PA, et al. 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017;70:24132.
Sarna S, Sahi T, Koskenvuo M, et al. Increased life expectancy of world class male athletes. Med Sci Sports Exerc. 1993;25:237–244.
Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:1422–1445.
David TE, Armstrong S, McCrindle BW, et al. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127:1485–1492.
Nishida H, Fukui T, Kasegawa H, et al. Causes of repair failure for degenerative mitral valve disease and reoperation outcomes. Eur J Cardiothorac Surg. 2018;53:1244–1250.
Kawamoto N, Fujita T, Fukushima S, et al. Functional mitral stenosis after mitral valve repair for type II dysfunction: determinants and impacts on long-term outcome. Eur J Cardiothorac Surg. 2018;54:453–459.
Ibrahim MF, David TE. Mitral stenosis after mitral valve repair for non-rheumatic mitral regurgitation. Ann Thorac Surg. 2002;73:34–36.
Bertrand PB, Verbrugge FH, Verhaert D, et al. Mitral valve area during exercise after restrictive mitral valve annuloplasty: importance of diastolic anterior leaflet tethering. J Am Coll Cardiol. 2015;65:452–461.
Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085–1092.
Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556–566.
Machado LR, Meneghelo ZM, Le Bihan DCS, et al. Preoperative left ventricular ejection fraction and left atrium reverse remodeling after mitral regurgitation surgery. Cardiovasc Ultrasound. 2014;12:45.
Grigioni F, Enriquez-Sarano M, Ling LH, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078–2085.
Starling MR. Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation. Circulation. 1995;92:811–818.
Bursi F, Enriquez-Sarano M, Jacobsen SJ, et al. Mitral regurgitation after myocardial infarction: a review. Am J Med. 2006;119:103–112.
Masri A, Al Halabi S, Karimianpour A, et al. Impact of additive mitral valve surgery to coronary artery bypass grafting on mortality in patients with coronary artery disease and ischaemic mitral regurgitation: a systematic review and meta-analysis of randomized trials and observational studies. Eur Heart J Qual Care Clin Outcomes. 2016;2:33–44.
Koprivanac M, Kelava M, Alansari S, et al. Degenerative mitral valve disease-contemporary surgical approaches and repair techniques. Ann Cardiothorac Surg. 2017;6:38–46.
David TE. Durability of mitral valve repair for mitral regurgitation due to degenerative mitral valve disease. Ann Cardiothorac Surg. 2015;4:417–421.

Auteurs

Adrien Blanc (A)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.

Olivier Lairez (O)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, France.
Medical School of Rangueil, Paul Sabatier University, Toulouse, France.
Department of Nuclear Medicine, University Hospital of Rangueil, Toulouse, France.
Heart Valve Center, University Hospital of Rangueil, Toulouse, France.

Eve Cariou (E)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Medical School of Rangueil, Paul Sabatier University, Toulouse, France.
Heart Valve Center, University Hospital of Rangueil, Toulouse, France.

Pauline Fournier (P)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Heart Valve Center, University Hospital of Rangueil, Toulouse, France.

Ana Maria Poenar (AM)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.

Bertrand Marcheix (B)

Medical School of Rangueil, Paul Sabatier University, Toulouse, France.
Heart Valve Center, University Hospital of Rangueil, Toulouse, France.
Department of Cardiac Surgery, University Hospital of Rangueil, Toulouse, France.

Christophe Cron (C)

Heart Valve Center, University Hospital of Rangueil, Toulouse, France.
Department of Cardiac Surgery, University Hospital of Rangueil, Toulouse, France.

Etienne Grunenwald (E)

Heart Valve Center, University Hospital of Rangueil, Toulouse, France.
Department of Cardiac Surgery, University Hospital of Rangueil, Toulouse, France.

Jean Porterie (J)

Medical School of Rangueil, Paul Sabatier University, Toulouse, France.
Heart Valve Center, University Hospital of Rangueil, Toulouse, France.
Department of Cardiac Surgery, University Hospital of Rangueil, Toulouse, France.

François Labaste (F)

Department of Cardiac Surgery, University Hospital of Rangueil, Toulouse, France.
Department of Anesthesiology, University Hospital of Rangueil, Toulouse, France ; and.

Meyer Elbaz (M)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Medical School of Rangueil, Paul Sabatier University, Toulouse, France.

Michel Galinier (M)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Medical School of Rangueil, Paul Sabatier University, Toulouse, France.

Didier Carrié (D)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Medical School of Purpan, Paul Sabatier University, Toulouse, France .

Yoan Lavie-Badie (Y)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, France.
Department of Nuclear Medicine, University Hospital of Rangueil, Toulouse, France.
Heart Valve Center, University Hospital of Rangueil, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH